Sector revisions BioMarin Pharmaceutical Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			5-day change	1st Jan Change
61.83 ^USD	+3.14%		+2.52%	+4.04%

18/02	Tarsus Pharmaceuticals, Inc. Appoints David E. I. Pyott to Its Board of Directors and Chairperson of Commercial Committee and as Member of Nominating Committee and Compensation Committee of the Board, Effective on February 18, 2026	CI
13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
BIOMARIN PHARMACEUTICAL INC.		23
REGENERON PHARMACEUTICALS, INC.		26
UCB		19
SAMSUNG BIOLOGICS CO.,LTD.		26
CSL LIMITED		16
BIOGEN INC.		29
INCYTE CORPORATION		22
INNOVENT BIOLOGICS, INC.		25
MODERNA, INC.		20
SWEDISH ORPHAN BIOVITRUM AB		11
BRIDGEBIO PHARMA, INC.		21
ALTEOGEN INC.		4
AVIDITY BIOSCIENCES, INC.		11
AXSOME THERAPEUTICS, INC.		20
KRYSTAL BIOTECH, INC.		9
GRIFOLS, S.A.		12
3SBIO INC.		11
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	1
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	-	-
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.		5
Average		16
Weighted average by Cap.		20